Table 1.

Commonly used growth factor compound.

Xenogenic bone block loaded with rhBMP-2

GBR using acellular dermal matrix (ADM) film combined with alveolar bone grafting vs. alveolar bone grafting combined with concentrated growth factor (CG).

Bilateral maxillary sinus and ridge augmentation procedures using rhBMP-2 combined with allograft and xenograft.

Horizontal ridge augmentation surgery with deproteinized bovine bone xenograft particles combined with rhPDGF BB with collagen membrane.

rhPDGF-BB GBR with beta-tricalcium phosphate (β-TCP)/hydroxyapatite (HA) as carrier.

Modified ridge split with rhPDGF-BB hydrated crushed cortical freeze-dried bone allograft and collagen membrane using

Deproteinized bovine bone added to autologous bone vs. deproteinized bovine bone added to autologous bone with rhPDGF-BB.

rhPDGF-BB in conjunction with autogenous bone and anorganic bovine-derived bone mineral and a barrier membrane to reconstruct a severe alveolar posterior maxillary bone defect.

rhBMP-2

rhPDGF-BB in conjunction with an overlying titanium mesh in posterior mandibular ridge defect.

Autogenous bone in conjunction with rhPDGF-BB and barrier membrane.

1:1 ratio of autogenous bone graft and deproteinized bovide bone particles with rhPDGF-BB.

Xenogenic bone substitute and collagen membrane coated with rhBMP-2 and implant insertion.